iBio Inc (IBIO)
1.70
-0.07
(-3.95%)
USD |
NYAM |
Apr 19, 16:00
1.70
0.00 (0.00%)
After-Hours: 20:00
iBio Cash and Short Term Investments (Quarterly): 2.788M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.788M |
| September 30, 2023 | 1.461M |
| June 30, 2023 | 4.301M |
| March 31, 2023 | 6.562M |
| December 31, 2022 | 9.625M |
| September 30, 2022 | 17.49M |
| June 30, 2022 | 33.52M |
| March 31, 2022 | 48.58M |
| December 31, 2021 | 57.38M |
| September 30, 2021 | 82.27M |
| June 30, 2021 | 96.97M |
| March 31, 2021 | 103.92M |
| December 31, 2020 | 107.65M |
| September 30, 2020 | 83.55M |
| June 30, 2020 | 55.11M |
| March 31, 2020 | 10.04M |
| December 31, 2019 | 3.637M |
| September 30, 2019 | 2.103M |
| June 30, 2019 | 4.421M |
| March 31, 2019 | 9.037M |
| December 31, 2018 | 13.36M |
| September 30, 2018 | 16.01M |
| June 30, 2018 | 15.93M |
| March 31, 2018 | 3.398M |
| December 31, 2017 | 7.31M |
| Date | Value |
|---|---|
| September 30, 2017 | 5.916M |
| June 30, 2017 | 8.088M |
| March 31, 2017 | 12.42M |
| December 31, 2016 | 16.33M |
| September 30, 2016 | 20.10M |
| June 30, 2016 | 23.01M |
| March 31, 2016 | 21.89M |
| December 31, 2015 | 6.732M |
| September 30, 2015 | 8.384M |
| June 30, 2015 | 9.494M |
| March 31, 2015 | 8.08M |
| December 31, 2014 | 7.363M |
| September 30, 2014 | 3.486M |
| June 30, 2014 | 3.59M |
| March 31, 2014 | 4.333M |
| December 31, 2013 | 5.678M |
| September 30, 2013 | 3.444M |
| June 30, 2013 | 4.414M |
| March 31, 2013 | 1.527M |
| December 31, 2012 | 2.819M |
| September 30, 2012 | 4.276M |
| June 30, 2012 | 5.624M |
| March 31, 2012 | 6.724M |
| December 31, 2011 | 0.6235M |
| September 30, 2011 | 1.523M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
1.461M
Minimum
Sep 2023
107.65M
Maximum
Dec 2020
38.49M
Average
17.49M
Median
Sep 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Lixte Biotechnology Holdings Inc | 4.204M |
| PAVmed Inc | 19.64M |
| Avalo Therapeutics Inc | 7.415M |
| Imunon Inc | 15.70M |
| Ocugen Inc | 39.46M |